More about

Bupropion

News
October 27, 2024
3 min read
Save

Smoking cessation prescriptions increase when patients have asthma

Smoking cessation prescriptions increase when patients have asthma

BOSTON — Smokers with asthma were more likely to be prescribed a smoking cessation treatment than smokers who did not have asthma, according to a poster at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

News
October 03, 2024
3 min read
Save

Tirzepatide, semaglutide more efficacious than other FDA-approved drugs for weight loss

Tirzepatide, semaglutide more efficacious than other FDA-approved drugs for weight loss

Tirzepatide and semaglutide confer greater weight loss than other FDA-approved obesity medications with no significantly higher risk for adverse events, according to findings from a network meta-analysis published in Obesity.

News
August 30, 2024
2 min read
Save

Less than 1% of Military Health System beneficiaries use an obesity medication

Less than 1% of Military Health System beneficiaries use an obesity medication

Obesity medications were prescribed to very few Military Health System beneficiaries between October 2017 and September 2022, according to a study published in Obesity.

News
February 14, 2024
4 min read
Save

Most adults with obesity are not prescribed obesity medication

Most adults with obesity are not prescribed obesity medication

Most adults with obesity were not prescribed an obesity medication from 2015 to 2023, and of those prescribed an agent, 55% had at least one prescription fill, according to study data published in Diabetes, Obesity and Metabolism.

News
December 27, 2023
3 min read
Save

Most adults prescribed obesity drugs discontinue use at 3 months

Most adults prescribed obesity drugs discontinue use at 3 months

More than 80% of adults who are prescribed an obesity medication discontinue taking them at 1 year, though persistence rates are higher for adults receiving semaglutide and liraglutide, according to study data.

News
October 17, 2023
1 min read
Save

Certain antidepressants may cause more weight gain over 2 years

Certain antidepressants may cause more weight gain over 2 years

DALLAS — Initiation and continued use of certain antidepressants may cause more weight gain over 2 years, according to research presented at ObesityWeek.

News
May 30, 2023
1 min read
Save

Naltrexone/bupropion maintenance therapy for binge-eating disorder superior to placebo

Naltrexone/bupropion maintenance therapy for binge-eating disorder superior to placebo

MIAMI BEACH, Fla. — Adults with binge-eating disorder who were given acute naltrexone/bupropion performed better with similar maintenance treatment compared with placebo, per data from the American Society of Clinical Psychopharmacology annual meeting.

News
March 23, 2023
2 min read
Save

Bupropion may promote cocaine abstinence in some opioid users

Bupropion may promote cocaine abstinence in some opioid users

In addition to a financial incentive, bupropion may help some people being treated for opioid use disorder to stop using cocaine, according to findings published in JAMA Network Open.

News
February 10, 2022
2 min read
Save

Web-based prescription of smoking-cessation therapy feasible, effective

Web-based prescription of smoking-cessation therapy feasible, effective

An intervention that utilized smoking-cessation therapy prescribed over the internet was feasible and effective, according to data published in Drug and Alcohol Dependence.

News
August 13, 2021
1 min read
Save

Axsome’s oral drug combination delays relapse of depression in phase 2 trial

Axsome Therapeutics’ AXS-05 achieved the primary endpoint of significantly delaying time to relapse of depression in patients with treatment-resistant depression in a phase 2 trial, according to a company press release.

View more